Related Experiment Video
Updated: Jul 17, 2026

08:13
Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
Published on: September 30, 2021
How we manage requests for recombinant factor VIIa (NovoSeven)
Prasad Mathew1, Toby L Simon, Kristin E Hunt
1Department of Pathology, University of New Mexico, New Mexico, USA.
Transfusion
|January 9, 2007
Summary
No abstract available in PubMed .
Related Concept Videos
Recombinant DNA
Overview
Bioequivalence studies: Biowaivers
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...

